Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Boehringer Ingelheim launches Sound Challenge app

Looks to raise awareness of rare lung disease IPF

Boehringer Ingelheim IPF Sound Challenge mobile app iPhone Android

Boehringer Ingelheim has launched a new mobile app as part of its push to raise awareness of the rare chronic lung disease idiopathic pulmonary fibrosis (IPF).

The IPF Sound Challenge iPhone and Android app aims to help doctors learn about the unique 'Velcro crackles' commonly heard in the lungs of patients with IPF and recognise them as a sign that further investigation could be needed.

The app plays a series of recorded auscultations of both diseased and healthy lungs in patients at rest, as captured through an electronic stethoscope, and quizzes listeners on what they are hearing.

The recordings can also be listened to via Boehringer's Sounds of IPF website which, along with its inIPF website and the Boehringer Ingelheim Idiopathic Pulmonary Fibrosis YouTube channel, marks an increase in its awareness efforts.

The company, which says its cancer drug nintedanib could be approved in IPF by the end of the year, is also working with online community PatientsLikeMe to enhance its efforts in IPF.

29th September 2014

From: Marketing, Healthcare

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Lucid Group Communications Limited

WE’RE ON A MISSION To enhance patients’ lives through communication that changes behaviour and improves patient health outcomes....

Latest intelligence

China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...
Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...

Infographics